# Ginger: Gingerols, Nausea, Pain, Doses, and Safety

- Canonical: https://nutrifit.health/knowledge/green-tea-ginger-polyphenols-safety
- Language: en
- Published: 2026-09-02T00:57:01.128Z
- Updated: 2026-10-02T18:35:40.318Z
- Author: NutriFit Editorial

> From pungent gingerols and shogaols to human trials on nausea, pain, and glycemic control. We explain the metabolism of components, 5-HT3 and NF-κB signaling, differences between powders and extracts, and clinical effect sizes. We provide a detailed analysis of pregnancy, severe vomiting, menstrual pain, drug interactions, and tolerability.

Ginger is recognized before it is named: by its fresh, spicy scent, the tingling on the tongue, and the warmth that remains after a sip. This sensory persuasiveness easily translates into a medical one: it seems that such a noticeable product must just as noticeably alter the body's functioning. The scientific history is more interesting than such an assumption. Ginger indeed possesses biologically active substances and human studies, but the palpable pungency, the alteration of cellular signaling, and symptom relief belong to different levels of evidence.

This gap is best seen in cases of nausea: ginger has been studied in pregnant women, cancer patients, and travelers, yet the results of these works cannot be combined into a universal antiemetic promise. Regarding pain and diabetes, the issue is even more nuanced: an improvement in a single score does not necessarily mean the restoration of a joint or the prevention of complications. To understand the practical place of a supplement, one must trace the path from the rhizome to the preparation, then to physiology, and only then to clinical results. It is precisely the form of the product and the cause of the symptoms that the official NCCIH review suggests taking into account.

## Rhizome, powder, and extract: the chemistry of a single spice

![Illustration for the section: Rhizome, powder, and extract: the chemistry of a single spice](https://api.nutrifit.health/api/v2/public/knowledge/files/images/nutrifit-ginger-20261002-01-forms.png)

What is called ginger root in everyday life is botanically a rhizome—the underground stem of *Zingiber officinale*. This is not a minor terminological correction: studies pertain to specific plant raw materials, not to any part of the plant or any product with a similar name. A fresh slice, dry powder, and capsule may originate from the same rhizome but undergo entirely different processing. Therefore, the image of ginger on packaging says nothing about its comparability to a clinical preparation.

Among the non-volatile pungent components, gingerols are distinguished, including 6-, 8-, and 10-gingerol. The numbers help to differentiate related molecules with different side chains; this is not a level of purity or a utility rating. Shogaols represent another group of compounds formed, in particular, during the dehydration of gingerols. Aroma and pungency are therefore not a single chemical characteristic: one cannot determine the content of substances, through which a researcher explains its effect, by the scent of the product.

Drying and heating change not only the water content but also the chemical profile of the raw material. In an analytical experiment, Ghasemzadeh compared sun-drying, tunnel-drying, and hot air-drying, measuring individual gingerols, shogaols, and essential oil. The formation of shogaols depended on the processing mode, so dry powder cannot be described as fresh ginger from which the water was simply removed. This is a study of food chemistry, not a treatment trial: a change in composition and activity in laboratory tests does not in itself determine benefit for the patient.

Extracts have another variable: the method of substance extraction. The solvent, degree of purification, and excipients determine which part of the initial composition ends up in the capsule. In an oncology study, Ryan used a purified liquid extract in an oil base; one capsule corresponded to 250 mg of rhizome and contained 8.5 mg of the sum of the active components named by the authors. Thus, the same number of grams on two labels can denote different things—the mass of the powder versus the raw material equivalent for an extract.

When reading dosages, it is useful to first clarify what exactly has been weighed. If the mass of the extract is indicated, it cannot be converted into the mass of dry rhizome without a coefficient and a description of the raw material; if the raw material equivalent is provided, this is not yet the gingerol content. Standardization by a chosen component makes the composition more reproducible but does not prove efficacy for any given disease. This is evident from the different preparations in the experiments of Ryan and Jiang: the word "ginger" unifies their origin, not their pharmacological identity.

Homemade infusions also cannot be dosed by the number of slices with the precision of a capsule study. The resulting composition is influenced by the quantity of raw material, the grinding, and the preparation, and for a specific cup, there is usually no analytical certificate. Tea can be chosen for its taste and convenience, but promising it the effect of a studied extract would be unfounded. Similarly, ginger cookies, candied pieces, and sweet drinks cannot be prescribed as an equivalent to powder: their nutritional role and the composition of the entire serving are different.

The difference in forms helps in understanding negative results, which often disappear from advertising. In a double-blind study by Niempoog, 60 patients with knee osteoarthritis received 1 g of powder in capsules daily for eight weeks or a placebo. No benefits were found regarding pain, symptoms, daily activities, or quality of life. This result applies to the specific powder and regimen; however, it convincingly demonstrates why a successful trial of one extract does not turn any ginger into an equally effective agent.

## What happens with molecules and nerve signals

![Illustration for the section: What happens with molecules and nerve signals](https://api.nutrifit.health/api/v2/public/knowledge/files/images/nutrifit-ginger-20261002-02-signals.png)

After ingestion, substances must be released from the preparation, absorbed, and survive transformations in the gut and liver. These stages link the chemical composition to potential action, which is why the concentration of the original molecule in a capsule is not equal to the concentration of that same molecule in the blood. In a study by Zick, 27 healthy volunteers received a single dose of a ginger preparation in escalating doses from 100 mg to 2 g. Blood samples were collected from 15 minutes to 72 hours to observe the fate of the components specifically, rather than changes in symptoms.

Free gingerols and 6-shogaol studied were not detected by the authors' method, but their conjugates—molecules with attached chemical groups—were identified. Such attachment, for example of glucuronic acid, changes the solubility and subsequent excretion of the substance. The estimated half-lives were less than two hours; this describes concentrations after a single dose, not a schedule of therapeutic action. Finally, “not detected” means the limit of measurement, not proof of the absolute absence of the molecule in all tissues.

The process of conjugation itself is also studied separately from supplement intake. He and colleagues investigated the glucuronidation of shogaols in vitro using human tissues and expressed UGT enzymes; UGT2B7 made a significant contribution to the conversion. This explains one of the metabolic pathways but does not allow for calculating the effect of a specific cup or predicting interaction with every medication. The activity of metabolites, local action in the gut, and delivery to the target tissue remain independent questions that cannot be settled by the mere fact of absorption.

Pungency is linked to the sensory system that perceives chemical irritation. In experiments by Dedov, synthesized gingerols activated the vanilloid receptor VR1, now called TRPV1, and caused calcium signals and ion currents in cultured rat sensory neurons. The ion channel here acts as a molecular gate: its opening changes the electrical state of the cell. Such an observation helps explain the sensation of spiciness but does not mean proven stimulation of blood circulation, fat burning, or pain relief after a regular dietary portion.

Another possible target was studied in connection with nausea: the serotonin 5-HT3 receptor, which is a channel involved in excitation transmission. Abdel-Aziz investigated gingerols and shogaol in cell models and an isolated guinea pig ileum. The compounds reduced current through the receptor channel and contractions caused by its activation; results pointed to modulation distinct from simple displacement of serotonin from the binding site. This is a preclinical model of potential action, so one cannot equate ginger to a medicinal 5-HT3 antagonist.

Anti-inflammatory explanations have a similar starting point. In mouse macrophages, Pan studied 6-shogaol after stimulation with lipopolysaccharide—a bacterial component that triggers an inflammatory response. The authors observed a decrease in the expression of iNOS and COX-2 and changes in the activation of NF-κB, a protein regulator of various gene functions; COX-2 participates in the formation of prostaglandins, and iNOS in the formation of nitric oxide. Here, an isolated compound was studied in a cellular system, not an inflamed human joint after a capsule.

These models are useful when they help formulate a testable question: will pain, food tolerance, or vomiting frequency change in a specific group of people? They become unreliable if the chain of “target—signal—symptom” is declared fully established without a human experiment. Even a positive pain trial does not prove that the improvement occurred specifically through the chosen cellular pathway. Clinical evaluation must therefore rely on the measured outcome, preserving pharmacokinetics and molecular observations as explanations of possible links, rather than as a ready-made therapeutic promise.

## Nausea during pregnancy: relief and the boundaries of home care

![Illustration for the section: Nausea during pregnancy: relief and the boundaries of home care](https://api.nutrifit.health/api/v2/public/knowledge/files/images/nutrifit-ginger-20261002-03-pregnancy.png)

Nausea in pregnancy is not reduced to "improper digestion" or a lack of willpower. In Fejzo's work, published online in 2023 and released in Nature in 2024, human biochemical and genetic data linked its severity to GDF15, a hormone of fetoplacental origin acting on the brainstem, and the mother's sensitivity to it. Additional mouse experiments investigated the dependence of the response on prior hormone exposure. This is an important physiological explanation; however, the work did not test ginger and does not show that it suppresses GDF15 or eliminates the cause of hyperemesis.

Symptomatic benefit has been studied in a different way: by randomized assignment of participants to a supplement or placebo. Vutyavanich included 70 women who sought care at a prenatal clinic at 17 weeks gestation or earlier. They received 1 g of ginger per day for four days, and the severity of nausea was assessed using a visual analog scale. The mean reduction in score was 2.1 points with ginger versus 0.9 with placebo; the difference in changes was 1.2 points, not "disappearance of nausea in the majority of pregnant women." Vutyavanich et al., 2001.

Vomiting in the same trial was assessed separately, by episodes over the preceding 24 hours. Their number also decreased more with ginger, but a small four-day trial does not determine the sustainability of the effect throughout the entire pregnancy. It is also not designed to reliably detect rare adverse outcomes. The practical value of the result lies in the possibility of short-term relief in the studied women, with subjective nausea and actual vomiting remaining two different treatment targets.

The 2014 Viljoen meta-analysis pooled 12 randomized trials involving 1,278 pregnant women. In a meta-analysis of two studies with a comparable visual scale, the advantage in reducing nausea was 1.20 points, with a 95% confidence interval of 0.56–1.84. For the number of vomiting episodes, no convincing overall advantage over placebo was found. The meta-analysis clarifies the picture here rather than increasing the effect: different forms of preparations, scales, timing, and methodological limitations do not allow promising an identical response to every woman.

Clinical guidelines take into account not only the presence of such a signal but also the clinical presentation. NICE suggests that women with mild to moderate nausea and vomiting who prefer a non-pharmacological option might try ginger. At the same time, the guidance provides for antiemetic drugs, intravenous fluids for more severe symptoms, and inpatient care for severe vomiting that does not respond to treatment. Therefore, the suggestion of ginger has a specific place in the choice of care, not the status of a mandatory first step before accessing medications.

In its 2024 guideline, RCOG draws attention to another side of the experience: many women have already tried home remedies before the consultation. For severe nausea and hyperemesis, there are no trials of the domestic use of ginger; patient surveys have described weak benefit and unpleasant reactions. The guideline warns specialists against suggesting ginger, which could delay effective treatment. This is not proof of the toxicity of any food portion, but a reminder that a repeated recommendation to drink tea can be clinically harmful if it replaces care for a person who can no longer eat or drink normally.

The issue of pregnancy safety requires data of a different scale. The Norwegian observational cohort by Heitmann involved 68,522 women; 1,020 reported using ginger. The authors did not find an increased risk of birth defects or a number of adverse outcomes, including preterm birth and low birth weight. However, this is not a randomized trial of a single dose: self-reporting, differences among users, and incomplete characterization of the preparations limit the conclusion. The large size of the general cohort does not turn an unknown concentrate into a remedy with proven safety at any gestation.

The 2025 EMA European monograph, despite the absence of a signal for malformations in the reviewed data, maintains a preference for avoiding the medicinal use of ginger during pregnancy as a precaution. This is a regulatory assessment of a specific herbal medicine, which should be distinguished from the NICE recommendation regarding the discussion of symptomatic relief. The choice depends on the severity of the condition, the preparation, and current local guidelines; data on lactation are also insufficient. The main practical observation is whether one can keep down fluids and food: an inability to do so requires medical evaluation rather than an increase in ginger dosage.

## Other types of nausea and gastric function

![Illustration for the section: Other types of nausea and gastric function](https://api.nutrifit.health/api/v2/public/knowledge/files/images/nutrifit-ginger-20261002-04-stomach.png)

Nausea represents the result of processing various signals, so the same sensation does not indicate the same cause. In motion sickness, vestibular inputs are significant; in chemotherapy, it is signals from the gut and other tissues triggered by the treatment; in pregnancy, it is the internal hormonal environment. For this reason, a successful result at an antenatal clinic does not predict a response in a car or an oncology ward. The NCCIH considers these situations separately and notes the uncertainty of the effect in chemotherapy and post-surgery.

A large trial by Ryan illustrates precisely this adjunctive use. Of 744 randomized oncology patients, 576 provided data for analysis; placebo was compared with extract equivalent to 0.5, 1, or 1.5 g of rhizome per day. A six-day course was started three days before chemotherapy, and two cycles were studied against a backdrop of a 5-HT3 antagonist and dexamethasone. The severity of acute nausea decreased, especially at doses of 0.5 and 1 g, but the result does not establish a benefit in place of pharmacological antiemetic protection.

A broader review by Choi in 2022 included 23 randomized trials and separated acute and delayed symptoms. In a meta-analysis of five trials, the frequency of acute nausea was not convincingly reduced: the odds ratio was 0.82, with a confidence interval of 0.44–1.52. This is a different outcome than the intensity of nausea in the Ryan study, so the results are not simply mutually exclusive. A positive signal for acute vomiting in a separate subgroup also does not provide a universal regimen: clinically differing trials have not established sustained control of all symptoms.

Regarding motion sickness, the regulatory wording and modern assessment of trials also do not fully coincide. The EMA maintains a prophylactic regimen for adults of 1–2 g of powder one hour before travel, whereas the NCCIH notes predominantly negative study results. The HMPC discussion protocol clarifies that the old indication has been retained for the sake of regulatory consistency and the absence of new safety concerns, although older studies do not meet today's standards. Thus, the dosage from the monograph becomes a description of a specific medicinal use rather than a guarantee for every traveler.

Acceleration of gastric emptying is studied separately from the antiemetic effect. In a cross-over, double-blind study by Hu, 11 patients with functional dyspepsia received 1.2 g of powder or placebo; an hour later, they were given 500 ml of low-calorie soup. The ultrasound median half-emptying time was 12.3 versus 16.1 minutes. This is the time for the removal of half of the test content, not the duration of full digestion of a meal, nor a direct measure of nutrient absorption.

Despite faster emptying, gastrointestinal sensations in these patients did not improve. Concentrations of motilin, ghrelin, and GLP-1 also did not change, so explaining the result by a proven increase in motilin is incorrect. The study lasted within the limits of a short laboratory observation and did not select patients specifically for delayed emptying. Its strength is the parallel measurement of function and well-being: changes in motility were not tacitly accepted as a treatment for dyspepsia.

For practical discussion, it is useful to clarify what an individual means by "poor digestion": early satiety, postprandial fullness, heartburn, or nausea. In Hu's study, patients with predominant reflux symptoms were excluded, so it cannot be used to promise relief from heartburn. Such a breakdown of symptoms allows for the selection of a relevant goal rather than evaluating everything based on a single sensation of warmth after a beverage. If a person tolerates drinking better, this may be a useful everyday observation, but it does not establish a diagnosis, a mechanism, or the necessity for a long-term course of treatment.

## Joint, muscle, and menstrual pain

![Illustration for the section: Joint, muscle, and menstrual pain](https://api.nutrifit.health/api/v2/public/knowledge/files/images/nutrifit-ginger-20261002-05-joints.png)

The anti-inflammatory reputation of ginger conflates conditions that require different treatments. In osteoarthritis, pain and movement restrictions are significant; in case of unaccustomed exercise, delayed onset muscle soreness; and in primary dysmenorrhea, cyclic pain without an established organic cause. The similarity in the involvement of mediators does not make these conditions a single disease. Therefore, a clinical conversation should start with a question about exactly what hurts and what function needs to be restored, rather than a general promise to "remove inflammation."

In the Altman and Marcussen trial, 261 patients with painful knee osteoarthritis were randomized for six weeks; 247 could be evaluated. The preparation EV.EXT 77 contained an extract of Zingiber officinale and Alpinia galanga, so this is a result of a combined herbal composition. A response, defined as a reduction in standing pain by at least 15 mm on a visual analog scale, was achieved by 63% of participants in the extract group and 50% in the placebo group. The difference is 13 percentage points, not a 63% reduction in pain for every patient.

The mean reduction in standing pain in the same study was 24.5 mm versus 16.4 mm; the additional benefit was 8.1 mm. Quality of life changed similarly in both groups, and gastrointestinal adverse events were recorded in 59 patients in the extract group versus 21 in the placebo group. These results allow for a discussion of a moderate symptomatic effect and its cost in terms of tolerability. They do not describe cartilage repair: structural slowing of the disease was not established by such a six-week comparison.

The Bartels meta-analysis combined five placebo-controlled trials with 593 adults. The standardized mean difference for pain was −0.30 and for functional limitations −0.22: these are small mean effects expressed through scale variability, not percentages of relief. Discontinuation of participation due to adverse events occurred more frequently with ginger, with a relative risk of 2.33 and a wide confidence interval of 1.04–5.22. A later 2020 review also emphasized the heterogeneity and low quality of part of the data, so clinical confidence cannot be assessed solely by a positive mean.

In the muscle experiment by Black, the task was much narrower: to induce soreness through eccentric loading of the elbow flexors. Two randomized trials included 34 and 40 volunteers, respectively, who took 2 g of crushed ginger daily for 11 days—either without heating or after heating—or a matching placebo. One day after the exercise, pain scores were 25% and 23% lower, respectively. These are relative differences in pain intensity, not the proportion of fully recovered athletes; heating did not enhance the effect.

The timing of the start is also important: the exercise occurred on the eighth day of intake, so the work does not describe the acute effect of a cup after a workout. In other indicators, the effects were smaller, and the reduction in soreness should not be considered proof of faster recovery of strength or better training adaptation. Small groups and funding by the McCormick Science Institute are also part of the outcome assessment. For an athlete, a reasonable goal of discussion is the tolerability of soreness during a specific load, with the maintenance of standard recovery planning, rather than an attempt to override excessive training with a supplement.

In primary dysmenorrhea, Ozgoli compared three approaches in 150 female students aged 18 and older. Alternately assigned groups took 250 mg of ginger powder, 250 mg of mefenamic acid, or 400 mg of ibuprofen four times a day during the first three days of menstruation. After one cycle, pain decreased in all groups, with no significant differences found between them. Alternate assignment is weaker than reliable randomized controlled trials, and the lack of differences does not prove equivalence: the trial does not establish the right to replace ibuprofen with ginger.

It is especially dangerous to assess menstrual pain solely by whether it can be temporarily muted. Pain that interferes with daily life, chronic pelvic pain, pain during sexual intercourse, and cyclic bowel symptoms are among the signs for which NICE suggests suspecting endometriosis. Results for primary dysmenorrhea do not extend to this condition and do not establish normalization of hormones or fertility. Symptomatic improvement is useful when it is part of a clear care plan, but it should not mask the need to investigate the cause of persistent pain.

## Glycemia and choosing a meaningful regimen

![Illustration for the section: Glycemia and choosing a meaningful regimen](https://api.nutrifit.health/api/v2/public/knowledge/files/images/nutrifit-ginger-20261002-06-glucose.png)

Metabolic promises are attractive because blood tests seem more objective than subjective pain. However, fasting glucose reflects a specific moment, while HbA1c is a cumulative indicator of hemoglobin glycation used to assess diabetes control. A small trial may find a change in these values and still say nothing about long-term vascular complications. Therefore, a supplement is evaluated relative to baseline disease control and standard therapy, rather than as an independent way to "regulate metabolism."

In the work of Khandouzi, 50 patients with type 2 diabetes were initially included in a randomized double-blind trial, and 41 people completed it. Against the background of standard therapy, they received 2 g of powder daily for 12 weeks or a placebo. The mean change in HbA1c was −0.77 percentage points with ginger and +0.02 with placebo; this is a change in the indicator expressed as a percentage, not a 77% relative reduction. The analysis of those who completed the course and the small sample size limit the robustness of the assessment.

The same work measured apolipoproteins and malondialdehyde, used as a marker of lipid peroxidation. For the latter, the groups differed even before the intervention, which complicates the interpretation of the subsequent change. These analyses are interesting for a research hypothesis but do not measure "cleansing the body" or a reduction in the probability of a heart attack. For a clinician, HbA1c and such research markers have different roles: the former helps manage diabetes, while the others do not turn a supplement into proven prevention of its complications.

Another human experiment shows why one cannot choose only an impressive figure. Mahluji randomized 64 patients to 2 g of ginger per day or placebo for two months; some indicators of insulin, calculated insulin sensitivity, and lipids improved. However, no significant changes in fasting glucose and HbA1c were found. The calculated insulin resistance index is not a direct measurement of all insulin activity, so discrepancies in outcomes should not be smoothed over with the general word "efficacy." Mahluji et al., 2013.

Combined assessments also depend on the set of studies. The Zhu 2018 meta-analysis included ten studies with 490 participants and reported positive metabolic effects; a 2024 review with five trials did not find a significant pooled effect on fasting glucose and HbA1c. The latter studied powder at 1.2–2 g per day for 4–12 weeks. Differences in selection and data comparability explain why one positive review does not conclude the issue, and standard glucose-lowering therapy should not be changed based on a promise on a package.

Doses in this article describe research regimens with different goals. Four days for nausea, eleven days around muscle exertion, and twelve weeks for diabetes do not form a single course that should be continued for the sake of all assumed effects. For a specific product, the composition, daily amount, and instructions are important, and for a specific task—a pre-selected outcome. If the goal is related to symptoms, it is useful to record their severity and tolerability; if it is related to diabetes, the assessment of tests and medications is conducted within the framework of specialist supervision.

When making everyday choices, one should pay attention to the entire product, not just the plant ingredient. A sweet ginger drink and a capsule powder can differ both in the content of ginger compounds and in the contribution of sugar to the diet. When discussing results, it is necessary to consider diet, frequency of intake, medications, and lifestyle changes simultaneously; otherwise, an effect is easily attributed to the latest supplement purchased. In practice, a good choice starts with a clear goal and a readable label, and continues with a readiness to discontinue intake if it is ineffective or poorly tolerated.

## Safety: Tolerability, medications, and reasons to seek help

![Illustration for the section: Safety: Tolerability, medications, and reasons to seek help](https://api.nutrifit.health/api/v2/public/knowledge/files/images/nutrifit-ginger-20261002-07-safety.png)

The most common adverse reactions to ginger are related to the digestive tract: abdominal discomfort, heartburn, diarrhea, and irritation of the mouth and throat. A product may prove unpleasant precisely to someone taking it for stomach comfort. This is not a beneficial "warming" effect, nor is it evidence that the product is actively working. If symptoms intensify, one should not increase the dose in the hope of overcoming the reaction; it is better to stop taking it and evaluate the link to the product.

EMA classifies gastric complaints, eructation, dyspepsia, heartburn, and nausea as frequent reactions to the described herbal medicine, that is, in the category of 1% to less than 10%. This frequency group is not a forecast for every cup of tea and every commercial extract. Instructions also depend on the indication and age, and the safety of an adult research dose cannot be extrapolated to a child. Allergy to the ingredient itself or the components of a mixture requires separate attention; a reaction that has occurred previously does not become less significant due to the food origin of the raw material.

The issue of bleeding requires distinguishing between platelet aggregation and an actual clinical event. In a systematic review by Marx, four of eight clinical studies found a decrease in aggregation, while four did not; two more observational studies also yielded mixed results. The form, doses, and participants varied significantly. Therefore, saying that ginger necessarily "thins the blood" is inaccurate, but it is equally inaccurate to promise no risk to a person with a coagulation disorder, thrombocytopenia, or a combination of several drugs affecting hemostasis.

The controlled trial by Jiang provides more specific but narrow data. Twelve healthy men received a single dose of 25 mg of warfarin alone or against the background of a ginger preparation equivalent to 3.6 g of rhizome per day, started a week prior and continued for another week. No changes in the pharmacokinetics of warfarin, the international normalized ratio, or the investigated aggregation were established. This is not a model of chronic anticoagulation in an elderly patient; when taking warfarin, direct anticoagulants, antiplatelet agents, and before surgery, the supplement must be discussed with the medical team, specifying the exact product.

In diabetes, a reason for caution arises from the research question itself regarding glucose reduction. Clinical data do not allow for a reliable frequency of hypoglycemia from combining ginger with a specific drug or calculating a dose change in advance. Therefore, a new supplement should be known to the specialist, especially if treatment already requires self-monitoring of glucose. Unauthorized discontinuation or reduction of prescribed drugs based on a single successful measurement deprives observation of its meaning and may disrupt disease control.

For pregnancy, the main immediate risk of home self-treatment is missing dehydration and the severity of the condition. Pronounced thirst, feeling unwell, drowsiness, and dark urine require attention; the inability to eat and drink normally is already included in the definition of a severe form. Abdominal pain, urinary symptoms, or vomiting first occurring after 16 weeks require consideration of other causes. In such a situation, another infusion does not replace evaluation: the person must receive help capable of restoring fluid intake, nutrition, and symptom control.

Liver risks associated with various herbal supplements should not be grouped together under the word "extract." LiverTox classifies ginger as an unlikely cause of clinically apparent liver injury, although it notes that systematic monitoring of liver parameters was absent in many trials. A single case has been described following the use of a commercial product with insufficiently characterized purity and composition. This is not a basis to declare ginger a typical hepatotoxin or a liver-protecting agent: in the case of jaundice or other suspicious symptoms, all products taken, including multi-ingredient mixtures, must be evaluated.

Finally, the simultaneous initiation of several supplements makes both the effect and any adverse reaction harder to interpret. For a discussion with a specialist, it is more useful to keep a record of the name, composition, regimen, and start date rather than limiting oneself to the phrase "it's just ginger." Successful use means clear relief of a specific problem with acceptable tolerability, rather than reaching a maximum dose. This approach leaves ginger a reasonable place in the diet and in the discussion of individual symptoms, while preserving timely diagnosis and treatment where spices are not sufficient.

## FAQ

### Can ginger tea replace the capsules used in studies?

The exact content of studied components in a home infusion is typically unknown. The mass of fresh raw material, dry powder, and the raw material equivalent for extracts are different values. Tea can be enjoyed as a beverage, but comparability to a clinical preparation based solely on the plant name is not established.

### Is dry ginger more beneficial than fresh because of shogaols?

Processing alters the chemical composition, but higher laboratory activity does not define clinical benefit. In muscle soreness trials, heating did not enhance the effect. The choice of form depends on the goal, composition, and tolerability. [Black Study](https://pubmed.ncbi.nlm.nih.gov/20418184/).

### Can I use ginger for pregnancy nausea?

This should be discussed with an obstetric specialist, taking into account the specific preparation and severity of symptoms. NICE allows for such an attempt in cases of mild or moderate nausea, while EMA recommendations for herbal medicine are more cautious. Inability to keep down fluids or food requires immediate medical attention. [NICE](https://www.nice.org.uk/guidance/ng201/chapter/recommendations).

### When should you not wait for home remedy effects during pregnancy vomiting?

If you are unable to retain fluids, feeling unwell, experiencing severe thirst, drowsiness, or dark urine, you need a medical assessment. Abdominal pain and late-onset vomiting also require investigation of causes. Ginger should not delay medical care. [RCOG](https://www.rcog.org.uk/for-the-public/browse-our-patient-information/pregnancy-sickness-nausea-and-vomiting-of-pregnancy-and-hyperemesis-gravidarum/).

### Does it speed up gastric emptying and therefore treat dyspepsia?

Functional changes and symptom relief are different outcomes. In a small trial using liquid test meals, emptying accelerated, but sensations did not improve. Based on this result, one cannot prescribe long-term treatment for dyspepsia or reflux. [Hu Study](https://www.wjgnet.com/1007-9327/full/v17/i1/105.htm).

### Why can't data on knee pain be generalized to all ginger products?

Trials differed in preparation, duration, and outcome measures. Positive studies with extracts also used galangal, and a separate trial of standard powder showed no advantage. Pain relief does not prove cartilage repair. [Niempoog Study](https://pubmed.ncbi.nlm.nih.gov/23964445/).

### Is it proven that ginger replaces ibuprofen for menstrual pain?

No: the absence of differences in one comparison does not prove treatment equivalence. Persistent or life-disrupting pelvic pain requires an investigation of the cause. Data for primary dysmenorrhea does not constitute treatment data for endometriosis. [NICE](https://www.nice.org.uk/guidance/ng73/chapter/Recommendations).

### Can I reduce diabetes medication after starting ginger?

You should not change treatment on your own. Results for the supplement regarding glucose and HbA1c are inconsistent, and there is no proven prevention of complications in the cited trials. Dosage and monitoring should be discussed as part of diabetes management. [2024 Meta-analysis](https://www.sciencedirect.com/science/article/pii/S2405457724002171).

### Does ginger necessarily thin the blood?

Such a generalization is not confirmed: human results on platelet aggregation are mixed. A laboratory marker is not synonymous with clinical bleeding risk. If you are taking anticoagulants, antiplatelets, or preparing for surgery, you must inform your medical team about the supplement. [Marx Review](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0141119).

### Is there a universal safe maximum dose?

The cited doses refer to different preparations, populations, and research durations. They do not establish a general ceiling for long-term monthly use, children, or unknown concentrations. Focus on the instructions for the specific product, your goals, and individual circumstances.

### Do I have to tolerate heartburn for the sake of the effect?

No: worsening tolerability is not an indicator of therapeutic strength. If discomfort increases, do not increase the dose and evaluate the connection to the product. Heartburn and irritation are known adverse reactions. [NCCIH](https://www.nccih.nih.gov/health/ginger).

### Does ginger protect the liver or, conversely, damage it?

There is no basis in the cited studies to promise liver protection. LiverTox considers clinically apparent liver injury from ginger unlikely, but the composition of mixtures and the completeness of monitoring matter. Jaundice requires evaluation of all substances being taken. [LiverTox](https://www.ncbi.nlm.nih.gov/books/NBK600585/).

## Sources

- [NCCIH. Ginger. Last Updated: February 2025](https://www.nccih.nih.gov/health/ginger)
- [Ghasemzadeh A, Jaafar HZE, Baghdadi A, Tayebi-Meigooni A. Formation of 6-, 8- and 10-Shogaol in Ginger through Application of Different Drying Methods: Altered Antioxidant and Antimicrobial Activity. Molecules. 2018;23(7):1646](https://pubmed.ncbi.nlm.nih.gov/29976903/)
- [Zick SM et al. Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiology, Biomarkers & Prevention. 2008;17(8):1930–1936](https://pubmed.ncbi.nlm.nih.gov/18708382/)
- [He L et al. Glucuronidation of [6]-shogaol, [8]-shogaol and [10]-shogaol by human tissues and expressed UGT enzymes: identification of UGT2B7 as the major contributor. RSC Advances. 2018. DOI: 10.1039/C8RA08466A](https://pubs.rsc.org/en/content/articlehtml/2018/ra/c8ra08466a)
- [Dedov VN et al. Gingerols: a novel class of vanilloid receptor (VR1) agonists. British Journal of Pharmacology. 2002;137(6):793–798](https://pubmed.ncbi.nlm.nih.gov/12411409/)
- [Abdel-Aziz H, Windeck T, Ploch M, Verspohl EJ. Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. European Journal of Pharmacology. 2006;530(1–2):136–143](https://pubmed.ncbi.nlm.nih.gov/16364290/)
- [Pan MH et al. 6-Shogaol suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. Molecular Nutrition & Food Research. 2008;52(12):1467–1477](https://pubmed.ncbi.nlm.nih.gov/18683823/)
- [Fejzo M et al. GDF15 linked to maternal risk of nausea and vomiting during pregnancy. Nature. 2024;625:760–767. Published online 13 December 2023](https://www.nature.com/articles/s41586-023-06921-9)
- [Vutyavanich T, Kraisarin T, Ruangsri R. Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebo-controlled trial. Obstetrics & Gynecology. 2001;97(4):577–582](https://pubmed.ncbi.nlm.nih.gov/11275030/)
- [Viljoen E, Visser J, Koen N, Musekiwa A. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutrition Journal. 2014;13:20](https://pmc.ncbi.nlm.nih.gov/articles/PMC3995184/)
- [Heitmann K, Nordeng H, Holst L. Safety of ginger use in pregnancy: results from a large population-based cohort study. European Journal of Clinical Pharmacology. 2013;69(2):269–277](https://pubmed.ncbi.nlm.nih.gov/22706624/)
- [NICE. Antenatal care (NG201). Recommendations: Nausea and vomiting](https://www.nice.org.uk/guidance/ng201/chapter/recommendations)
- [Nelson-Piercy C et al.; Royal College of Obstetricians and Gynaecologists. The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69). BJOG. 2024;131(7):e1–e30](https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/1471-0528.17739)
- [EMA/HMPC/885789/2022. European Union herbal monograph on Zingiber officinale Roscoe, rhizoma. Final – Revision 1. 07 May 2025](https://www.ema.europa.eu/system/files/documents/herbal-monograph/zingiberis-rhizoma-mo_en.pdf)
- [Ryan JL et al. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: A URCC CCOP study of 576 patients. Supportive Care in Cancer. 2012;20(7):1479–1489](https://pmc.ncbi.nlm.nih.gov/articles/PMC3361530/)
- [Choi J, Lee J, Kim K, Choi HK, Lee SA. Effects of Ginger Intake on Chemotherapy-Induced Nausea and Vomiting: A Systematic Review of Randomized Clinical Trials. Nutrients. 2022;14(23):4982](https://www.mdpi.com/2072-6643/14/23/4982)
- [EMA/HMPC/589139/2024. Minutes of the HMPC meeting held on 18–20 November 2024](https://www.ema.europa.eu/en/documents/minutes/minutes-hmpc-meeting-18-20-november-2024_en.pdf)
- [Hu ML et al. Effect of ginger on gastric motility and symptoms of functional dyspepsia. World Journal of Gastroenterology. 2011;17(1):105–110](https://www.wjgnet.com/1007-9327/full/v17/i1/105.htm)
- [Niempoog S, Pawa KK, Amatyakul C. The efficacy of powdered ginger in osteoarthritis of the knee. Journal of the Medical Association of Thailand. 2012;95 Suppl 1:S59–S64](https://pubmed.ncbi.nlm.nih.gov/23964445/)
- [Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis & Rheumatism. 2001;44(11):2531–2538](https://onlinelibrary.wiley.com/doi/10.1002/1529-0131%28200111%2944%3A11%3C2531%3A%3AAID-ART433%3E3.0.CO%3B2-J)
- [Bartels EM et al. Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis and Cartilage. 2015;23(1):13–21](https://pubmed.ncbi.nlm.nih.gov/25300574/)
- [Araya-Quintanilla F et al. Effectiveness of Ginger on Pain and Function in Knee Osteoarthritis: A PRISMA Systematic Review and Meta-Analysis. Pain Physician. 2020;23(2):E151–E161](https://pubmed.ncbi.nlm.nih.gov/32214292/)
- [Black CD, Herring MP, Hurley DJ, O'Connor PJ. Ginger (Zingiber officinale) reduces muscle pain caused by eccentric exercise. The Journal of Pain. 2010;11(9):894–903](https://pubmed.ncbi.nlm.nih.gov/20418184/)
- [Ozgoli G, Goli M, Moattar F. Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. The Journal of Alternative and Complementary Medicine. 2009;15(2):129–132](https://pubmed.ncbi.nlm.nih.gov/19216660/?dopt=Abstract)
- [NICE. Endometriosis: diagnosis and management (NG73). Recommendations](https://www.nice.org.uk/guidance/ng73/chapter/Recommendations)
- [Khandouzi N et al. The Effects of Ginger on Fasting Blood Sugar, Hemoglobin A1c, Apolipoprotein B, Apolipoprotein A-I and Malondialdehyde in Type 2 Diabetic Patients. Iranian Journal of Pharmaceutical Research. 2015;14(1):131–140](https://pmc.ncbi.nlm.nih.gov/articles/PMC4277626/)
- [Mahluji S et al. Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. International Journal of Food Sciences and Nutrition. 2013;64(6):682–686](https://pubmed.ncbi.nlm.nih.gov/23496212/)
- [Zhu J, Chen H, Song Z, Wang X, Sun Z. Effects of Ginger (Zingiber officinale Roscoe) on Type 2 Diabetes Mellitus and Components of the Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine. 2018;2018:5692962](https://pubmed.ncbi.nlm.nih.gov/29541142/)
- [The effect of oral supplementation of ginger on glycemic control of patients with type 2 diabetes mellitus - A systematic review and meta-analysis. Clinical Nutrition ESPEN. 2024;63:615–622. DOI: 10.1016/j.clnesp.2024.07.011](https://www.sciencedirect.com/science/article/pii/S2405457724002171)
- [Marx W et al. The Effect of Ginger (Zingiber officinale) on Platelet Aggregation: A Systematic Literature Review. PLOS ONE. 2015;10(10):e0141119](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0141119)
- [Jiang X et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology. 2005;59(4):425–432](https://pmc.ncbi.nlm.nih.gov/articles/PMC1884814/)
- [RCOG. Pregnancy sickness (nausea and vomiting of pregnancy and hyperemesis gravidarum)](https://www.rcog.org.uk/for-the-public/browse-our-patient-information/pregnancy-sickness-nausea-and-vomiting-of-pregnancy-and-hyperemesis-gravidarum/)
- [Ginger. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Updated February 10, 2024](https://www.ncbi.nlm.nih.gov/books/NBK600585/)